Pneumocystis jirovecii Pneumonia in patients with or without AIDS, France

Emerging Infectious Diseases

Volumn 20, Issue 9, 2014, Pages 1490-1497

  Roux, Antoine ^b   Canet, Emmanuel ^a   Valade, Sandrine ^a   Gangneux Robert, Florence ^c   Hamane, Samia ^a   Lafabrie, Ariane ^a   Maubon, Daniéle ^e   Debourgogne, Anne ^f   Le Gal, Soléne ^g   Dalle, Fréderic ^h   Leterrier, Marion ⁱ   Toubas, Dominique ^j   Pomares, Christelle ^k   Bellanger, Anne Pauline ^l   Bonhomme, Julie ^m   Berry, Antoine ⁿ   Durand Joly, Isabelle ^o   Magne, Denis ^p   Pons, Denis ^d   Hennequin, Christophe ^p   Maury, Eric ^p   Roux, Patricia ^p   Azoulay, Élie ^a   more..

^a SAINT LOUIS HOSPITAL   (France)

^b FOCH HOSPITAL   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

^g BREST UNIVERSITY HOSPITAL   (France)

^h DIJON UNIVERSITY HOSPITAL   (France)

ⁱ NANTES UNIVERSITY HOSPITAL   (France)

^j REIMS UNIVERSITY HOSPITAL   (France)

^k CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^l UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^m CHU CÔTE DE NACRE   (France)

ⁿ TOULOUSE UNIVERSITY HOSPITAL   (France)

^o LILLE UNIVERSITY HOSPITAL   (France)

^p HÔPITAL SAINT ANTOINE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; C REACTIVE PROTEIN; CALCINEURIN INHIBITOR; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; FLUDARABINE; FUNGUS ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHOTREXATE; PENTAMIDINE; PRIMAQUINE; RITUXIMAB; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; CD4 LYMPHOCYTE COUNT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FRANCE; HOSPITAL ADMISSION; HUMAN; HYPOXEMIA; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OXYGEN SATURATION; OXYGEN SUPPLY; PNEUMOCYSTIS JIROVECI; PNEUMONIA; POST TREATMENT SURVIVAL; PROSPECTIVE STUDY; RISK FACTOR; THORAX RADIOGRAPHY; TREATMENT DURATION; ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CLINICAL TRIAL; FEMALE; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; RISK;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MORTALITY; ODDS RATIO; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84906246024     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2009.131668     Document Type: Article

References (27)

1. Crothers K, Huang L, Goulet JL, Goetz MB, Brown ST, Rodriguez-Barradas MC, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2011;183:388-95. http://dx.doi.org/10.1164/ rccm.201006-0836OC
2. Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010;304:321-33. http://dx.doi.org/10.1001/ jama.2010.1004
3. Catherinot E, Lanternier F, Bougnoux ME, Lecuit M, Couderc LJ, Lortholary O. Pneumocystis jirovecii pneumonia. Infect Dis Clin North Am. 2010;24:107-38. http://dx.doi.org/10.1016/j.idc.2009.10.010
4. Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350:2487-98. http://dx.doi.org/10.1056/NEJMra032588
5. Bollée G, Sarfati C, Thiery G, Bergeron A, de Miranda S, Menotti J, et al. Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients. Chest. 2007;132:1305-10. http://dx.doi. org/10.1378/chest.07-0223
6. Roblot F, Godet C, Le Moal G, Garo B, Faouzi Souala M, Dary M, et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis. 2002;21:523-31. http://dx.doi.org/10.1007/s10096-002-0758-5
7. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc. 1996;71:5-13. http://dx.doi.org/10.4065/71.1.5
8. Zahar JR, Robin M, Azoulay E, Fieux F, Nitenberg G, Schlemmer B. Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study. Clin Infect Dis. 2002;35:929-34. http://dx.doi.org/10.1086/342338
9. Limper AH, Offord KP, Smith TF, Martin WJ II. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis. 1989;140:1204-9. http://dx.doi.org/10.1164/ajrccm/140.5.1204
10. Arend SM, Kroon FP, van't Wout JW. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arch Intern Med. 1995;155:2436-41. http://dx.doi. org/10.1001/archinte.1995.00430220094010
11. Nüesch R, Bellini C, Zimmerli W. Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients. Clin Infect Dis. 1999;29:1519-23. http://dx.doi.org/10.1086/313534
12. Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med. 1984;100:663-71. http://dx.doi.org/10.7326/0003-4819-100-5-663
13. Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A, et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med. 2010;182:1038-46. http://dx.doi.org/10.1164/ rccm.201001-0018OC
14. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc. 2007;82:1052-9. http://dx.doi. org/10.4065/82.9.1052
15. Ogawa J, Harigai M, Nagasaka K, Nakamura T, Miyasaka N. Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium-or high-dose corticosteroid therapy. Mod Rheumatol. 2005;15:91-6. http://dx.doi.org/10.3109/PL00021707
16. Tasaka S, Tokuda H. Pneumocystis jirovecii pneumonia in non-HIVinfected patients in the era of novel immunosuppressive therapies. J Infect Chemother. 2012;18:793-806. http://dx.doi.org/10.1007/ s10156-012-0453-0
17. Delclaux C, Zahar JR, Amraoui G, Leleu G, Lebargy F, Brochard L, et al. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virusinfected patients: retrospective study of 31 patients. Clin Infect Dis. 1999;29:670-2. http://dx.doi.org/10.1086/598651
18. de Boer MG, Kroon FP, le Cessie S, de Fijter JW, van Dissel JT. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis. Transpl Infect Dis. 2011;13:559-69. http://dx.doi. org/10.1111/j.1399-3062.2011.00645.x
19. Martin SI, Fishman JA; AST Infectious Disease Community of Practice. Pneumocystis pneumonia in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):272-9. http://dx.doi.org/10.1111/ajt.12119
20. Anand S, Samaniego M, Kaul DR. Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis. Transpl Infect Dis. 2011;13:570-4. http://dx.doi. org/10.1111/j.1399-3062.2011.00692.x
21. To KK, Wong SC, Xu T, Poon RW, Mok KY, Chan JF, et al. Use of nasopharyngeal aspirate for diagnosis of Pneumocystis pneumonia. J Clin Microbiol. 2013;51:1570-4. http://dx.doi. org/10.1128/JCM.03264-12
22. Barbier F, Coquet I, Legriel S, Pavie J, Darmon M, Mayaux J, et al. Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med. 2009;35:1678-86. http://dx.doi. org/10.1007/s00134-009-1559-4
23. Bozzette SA, Sattler FR, Chiu J, Wu AW, Gluckstein D, Kemper C, et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med. 1990;323:1451-7. http://dx.doi.org/10.1056/ NEJM199011223232104
24. Gagnon S, Boota AM, Fischl MA, Baier H, Kirksey OW, La Voie L. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. N Engl J Med. 1990;323:1444-50. http://dx.doi.org/10.1056/NEJM199011223232103
25. Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest. 1998;113:1215-24. http://dx.doi.org/10.1378/chest.113.5.1215
26. Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest. 2009;135:655-61. http://dx.doi.org/10.1378/chest.08-1309
27. Alanio A, Desoubeaux G, Sarfati C, Hamane S, Bergeron A, Azoulay E, et al. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect. 2011;17:1531-7. http://dx.doi.org/10.1111/j.1469-0691.2010.03400.x